Handok Hires Cho Jeong-yol to replace Kim Chul-joon as President
September 05, 2018
Share
Handok appointing former head of Korea's top car sharing firm SoCar as its new president. Handok named Cho Jeong-yol to replace Kim Chul-joon, who has been managing the company for
the past 10 years under CEO and Chairman Kim Young-jin. With the appointment, Cho became the first female president in the company's history (beginning in 1954) and the second among Korean pharmaceutical firms, following Yoo Hui-won at Bukwang Pharmaceutical. Cho's appointment is an unconventional move for Handok, as her career background has mostly been in consumer goods industries rather than drug manufacturing.
HANDOK Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. It also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.